Next year’s Java release is slated to include a performance boost for the G1 garbage collector and opt-in support for HTTP/3.

Alert: Top Cash Back Card Now Offers 0% Intro APR Until Nearly 2027 Enjoy 0% intro APR on purchases and balance transfers for 15 months—plus up to 5% cash back in popular categories. Let's discuss ...

Recursion Pharmaceuticals has significantly lagged the market since its 2021 IPO. The company's potentially revolutionary approach has yet to produce results. The stock's upside is enormous if ...

At RustConf 2025 in Seattle, Microsoft, Amazon, and the broader developer community marked key milestones for Rust — an ...

One of the first things about Minecraft you’ll notice is needing to decide which type or version to use. Bedrock and Java exist and to the untrained eye, neither ...

We recently published 12 Best Healthcare Stocks to Buy Under $30. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best healthcare stocks. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a ...

Recursion Pharmaceuticals reported significant growth in sales and revenue for Q2 and the first half of 2025 but also experienced widening net losses. The release of their Boltz-2 model underscored a ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...